I did some quick sums - we could’ve sold it as 6% Spodumene at around A$27m if we converted it at market rates (USD6500-7000).
This does not take into account the cost of converting it.
Essentially we haven’t really lost much in selling it as DSO rather than concentrate.
Ann: Inaugural DSO Tender, page-10
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CXO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $213.6M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 9.6¢ | $2.676M | 26.86M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 160000 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 953527 | 8 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| CXO (ASX) Chart |